-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
-
UCLA's Scooter Jackson named Week 11 Lott IMPACT Trophy Player of the Week
-
Paris Hilton Guides Loti as Chief Advocacy Officer to Put Digital Identity Protection in Everyone's Hands
-
Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year Partnership Built for "Speed to Decision"
-
Who Does the Best Testosterone Replacement Therapy in Las Vegas?
-
CMP 2026-2027 Nonprofit Leadership Pulse Check
-
Nexteer's HMDD Wins Innovation Awards from PACE Pilot, CES and AutoTech Breakthrough
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
More Than Keyboards: Epomaker Brings Its Gaming World to G-STAR 2026
Hepatitis B vaccine for newborns faces scrutiny in US
Experts appointed by the Trump administration's vaccine-skeptic Health Secretary Robert F. Kennedy Jr are expected to review newborn hepatitis B vaccines on Thursday, considering whether to delay the shots despite opposition from many doctors.
The newly anointed Advisory Committee on Immunization Practices (ACIP) members are slated to meet for two days in Atlanta, Georgia, to follow-up on a September meeting that resulted in new recommendations for Covid-19 and measles vaccinations.
Under Kennedy, ACIP has initiated a broad review of the safety of several vaccines, some of which have been in use for decades.
The shift led by the nation's health chief -- who has long voiced anti-vaccine rhetoric despite his lack of medical credentials -- is causing alarm in the American medical and scientific community.
Experts have warned about dropping immunization rates and the return of deadly contagious diseases like the measles, which caused several deaths in 2025.
"Any changes this ACIP makes will certainly not be based in facts or evidence, but rather ideology," said Sean O'Leary, an infectious disease and pediatric specialist who has been critical of the lack of qualifications among the committee's new members.
- First 24 hours -
Since 1991, US health officials have recommended the administration of the hepatitis B vaccine for newborn infants, as the viral liver disease exposes infected individuals to a high risk of death from cirrhosis or liver cancer.
"Ninety percent of babies infected with hepatitis B will go on to have chronic liver disease. Of those, a quarter will die from their hepatitis B infection. These are entirely preventable deaths," O'Leary said.
But anti-vax groups and President Donald Trump alike have pushed back on the practice, with Trump insisting in September that children should not be vaccinated against hepatitis B until the age of 12, rather than soon after birth, saying: "Hepatitis B is sexually transmitted. There's no reason to give a baby that's almost just born hepatitis B."
Medical experts condemned Trump's assertions, saying newborns can be infected by their mother during pregnancy or childbirth, and delaying vaccines would lead to lower vaccination rates overall because of inconsistent access to medical care in the United States.
An analysis published by a team of researchers from the University of Minnesota this week looked at more than 400 studies, concluding there was no benefit to delaying the hepatitis B vaccine, but there are "critical risks of changing current US recommendations."
- Loss of trust -
The repercussions of the ACIP's vaccine recommendations are broad because the federal guidelines often dictate whether vaccines are paid for by health insurance in the United States, where childbirth can be a major expense and the price of a single vaccine can be hundreds of dollars.
But the committee's influence is waning amid withering criticism from the American scientific and medical community, with Democratic-led states announcing they will no longer follow its recommendations.
"States are forming their own advisory committees because they don't trust anything that's going on under the auspices of Robert F. Kennedy Jr, who is an avowed anti-vaccine activist and science denialist," pediatrician Paul Offit told AFP.
"Everybody that watches the ACIP meetings just holds their breath, waiting to see what dangerous thing they advance next."
D.Johnson--AT